You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Earlier this year, Novigenix and collaborators were awarded up to €1 million to develop a blood-based multi-omics colorectal cancer assay.
Q2 Solutions will run Adaptive's NGS-based immune cell receptor profiling assay for its pharma and biotech clients, potentially in COVID-19 vaccine trials.
Plans are underway to add genomics data from various Danish cohorts to the browser, which will provide greater insight into disease progression.
Rheos will access data from PatientsLikeMe's DigitalMe biomarker discovery program, which collected molecular and other biological data from participants.
Under the non-exclusive partnership, Emedgene will integrate its genome interpretation application into Illumina's TruSight software suite.
Ovation offers laboratory information management system and laboratory information system software for molecular diagnostic test development.
The firm said it will use the financing for ongoing development of software and learning models.
The partnership will integrate Milaboratories' MiXCR software into Enpicom's ImmunoGenomix platform for immune repertoire sequencing.
The program uses an informatics system that converts genotype results to "traffic lights" telling clinicians whether a drug is acceptable for a certain patient.
Some are comparing iGenomics, a former high school intern's creation, to the fictional "medical tricorder" of "Star Trek" fame.
Through this partnership, the companies hope to help oncologists make better testing and treatment decisions, as well as improve clinical trial matching.
The company said it will use the funding to integrate Oxford Nanopore Technologies' ultra-long read genomic sequencing into its service.
The methods, both published in Nature Biotechnology this week, result in completely phased haplotypes, without the need for sequencing parental samples.
By chopping RNA-seq reads into smaller bits, UW-Tacoma data scientists are able to cut the alignment step to one minute, but the approach has skeptics.
The Stanford University spinout cofounded by Euan Ashley will use the funding to develop its microfluidics-based cell sorting and analysis technology.
As a formal not-for-profit, the group is able to raise funds from private entities and enter into formal contracts as it positions itself as an international standards organization.
San Francisco Otolaryngology hopes that 2bPrecise's PGx technology can help manage the medication burden on older patients and improve symptoms of dementia.
The products analyze various datasets including a patient's genetic and metabolic profiles, clinical history, and demographics to inform prescribing decisions.
The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.
Led by DNAstack and supported by Canada's Digital Technology Supercluster, COVID Cloud looks to build a nationwide bioinformatics infrastructure to address the pandemic.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.